Rishi Surana, MD, PhD

Rishi is a medical oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Insitute and is also an active member of the Immune Effector Cell (IEC) program within Dana-Farber, working to bring novel cellular therapies to patients with gastrointestinal malignancies. Rishi received his MD/PhD from Georgetown University prior to completing internal medicine residency at Oregon Health and Science University (OHSU). He then completed his hematology/oncology fellowship at the University of Texas MD Anderson Cancer Center prior to joining the faculty at Dana-Farber. Rishi is actively working to bring many of the discoveries from the Freed-Pastor laboratory to the clinic.